FDG PET/CT for early prediction of response to neoadjuvant therapy in HER2+breast cancer: validation in a multicentric population

被引：0
|
作者：
Tisserand, S. [1 ]
Kanoun, S. [1 ]
Blanc, J. [1 ]
Coudert, B. [1 ]
Berriolo-Riedinger, A. [1 ]
Cachin, F. [2 ]
Champion, L. [3 ]
Humbert, O. [4 ]
Salaun, P. [5 ]
Mognetti, T. [6 ]
Kerrou, K. [7 ]
机构：
[1] Ctr Georges Francois Leclerc, Dijon, France
[2] Ctr Jean Perrin, Clermont Ferrand, France
[3] Inst Curie, Paris, France
[4] Ctr Antoine Lacassagne, Nice, France
[5] CHU Morvan, Brest, France
[6] Ctr Leon Berard, Lyon, France
[7] Hop Tenon, Paris, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EPS-009
引用
收藏
页码：S305 / S306
页数：2
相关论文
共 50 条
  • [41] Integration of metabolomics and transcriptomics to reveal potential biomarkers associated with treatment response of neoadjuvant therapy in HER2+breast cancer
    Zhang, N.
    Xiang, Y.
    Jing, Z.
    Yu, F.
    Zeng, J.
    Pan, X.
    Zhou, W.
    Liang, X.
    Yue, Y.
    Zhang, H.
    Deng, Y.
    Deng, S.
    Mo, S.
    Jiang, X.
    Zeng, X.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S249 - S249
  • [42] The Role of Interim 18F-FDG PET/CT in Predicting Early Response to Neoadjuvant Chemotherapy in Breast Cancer
    Pahk, Kisoo
    Rhee, Seunghong
    Cho, Jaehyuk
    Seo, Minhee
    Lee, Sinae
    Park, Taegyu
    Park, Soyeon
    Lee, Eunsub
    Park, Kyung Hwa
    Kim, Chulhan
    Eo, Jae Seon
    Kim, Sungeun
    Choe, Jae Gol
    [J]. ANTICANCER RESEARCH, 2014, 34 (08) : 4447 - 4455
  • [43] Basal 18F-FDG PET/CT as a predictive biomarker of tumor response for neoadjuvant therapy in breast cancer
    Garcia Vicente, A. M.
    Soriano Castrejon, A.
    Pruneda-Gonzalez, R. E.
    Fernandez Calvo, G.
    Munoz Sanchez, M. M.
    Alvarez Cabellos, R.
    Espinosa Aunion, R.
    Relea Calatayud, F.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2016, 35 (02): : 81 - 87
  • [44] Inhomogeneous PET/CT-FDG response to therapy in metastatic breast cancer
    Espinet, Carina
    Rager, Olivier
    Ulaner, Gary
    Jochelson, Maxine
    Weber, Wolfgang
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [45] Breast cancer: treatment response assessment with FDG-PET/CT in the neoadjuvant and in the metastatic setting
    David Groheux
    Gary A. Ulaner
    Elif Hindie
    [J]. Clinical and Translational Imaging, 2023, 11 : 439 - 452
  • [46] Breast cancer: treatment response assessment with FDG-PET/CT in the neoadjuvant and in the metastatic setting
    Groheux, David
    Ulaner, Gary A.
    Hindie, Elif
    [J]. CLINICAL AND TRANSLATIONAL IMAGING, 2023, 11 (05) : 439 - 452
  • [47] Early and delayed prediction of axillary lymph node neoadjuvant response by 18F-FDG PET/CT in patients with locally advanced breast cancer
    Garcia Vicente, Ana Maria
    Soriano Castrejon, Angel
    Leon Martin, Alberto
    Relea Calatayud, Fernanda
    Munoz Sanchez, Maria del Mar
    Cruz Mora, Miguel Angel
    Jimenez Londono, German Andres
    Espinosa Aunion, Ruth
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (07) : 1309 - 1318
  • [48] Early and delayed prediction of axillary lymph node neoadjuvant response by 18F-FDG PET/CT in patients with locally advanced breast cancer
    Ana María García Vicente
    Ángel Soriano Castrejón
    Alberto León Martín
    Fernanda Relea Calatayud
    María del Mar Muñoz Sánchez
    Miguel Ángel Cruz Mora
    Germán Andrés Jiménez Londoño
    Ruth Espinosa Aunión
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 1309 - 1318
  • [49] Early and delayed prediction of axillary lymph node neoadjuvant response by18F-FDG PET/CT in patients with locally advanced breast cancer
    Garcia Vicente, A.
    Soriano Castrejon, A.
    Leon Martin, A.
    Relea Calatayud, F.
    Cruz Mora, M.
    Chacon Lopez-Muniz, I.
    Munoz Sanchez, M.
    Munoz Madero, V.
    Espinosa Aunion, R.
    Gonzalez Ageitos, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S214 - S214
  • [50] Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)
    Beitsch, Peter
    Whitworth, Pat
    Baron, Paul
    Rotkis, Michael C.
    Mislowsky, Angela M.
    Richards, Paul D.
    Murray, Mary K.
    Pellicane, James V.
    Dul, Carrie L.
    Nash, Charles H.
    Stork-Sloots, Lisette
    de Snoo, Femke
    Untch, Sarah
    Lee, Laura A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (09) : 2539 - 2546
12345